790 results on '"Carmeli Y"'
Search Results
2. Population pharmacokinetics of colistin and the relation to survival in critically ill patients infected with colistin susceptible and carbapenem-resistant bacteria
3. Estimating the association between antibiotic exposure and colonization with extended-spectrum β-lactamase-producing Gram-negative bacteria using machine learning methods: a multicentre, prospective cohort study
4. Microbiological diagnostics of bloodstream infections in Europe—an ESGBIES survey
5. A 5-day course of oral antibiotics followed by faecal transplantation to eradicate carriage of multidrug-resistant Enterobacteriaceae: a randomized clinical trial
6. Combining VITEK® 2 with colistin agar dilution screening assist timely reporting of colistin susceptibility
7. Prevalence of anti-hepatitis B surface antibodies among children and adolescents vaccinated in infancy and effect of booster dose administered within a pilot study
8. The negative impact of antibiotic resistance
9. A multicenter study of the clonal structure and resistance mechanism of KPC-producing Escherichia coli isolates in Israel
10. Bloodstream infections among carriers of carbapenem-resistant Klebsiella pneumoniae: etiology, incidence and predictors
11. A case-control study to identify predictors of 14-day mortality following carbapenem-resistant Acinetobacter baumannii bacteraemia
12. Risk factors for colonization with extended-spectrum beta-lactamase-producing enterobacteriaceae on admission to rehabilitation centres
13. Trends and changes in Clostridium difficile diagnostic policies and their impact on the proportion of positive samples: a national survey
14. A multinational study of colonization with extended spectrum β-lactamase-producing Enterobacteriaceae in healthcare personnel and family members of carrier patients hospitalized in rehabilitation centres
15. Time to Detection with BacT/Alert FA Plus Compared to BacT/Alert FA Blood Culture Media
16. Detection and characterization of carbapenemase-producing Enterobacteriaceae in wounded Syrian patients admitted to hospitals in northern Israel
17. Asymptomatic rectal carriage of blaKPC producing carbapenem-resistant Enterobacteriaceae: who is prone to become clinically infected?
18. Gastrointestinal colonization by KPC-producing Klebsiella pneumoniae following hospital discharge: duration of carriage and risk factors for persistent carriage
19. A binational cohort study of intestinal colonization with extended-spectrum β-lactamase-producing Proteus mirabilis in patients admitted to rehabilitation centres
20. Multicenter, Prospective Validation of a Phenotypic Algorithm to Guide Carbapenemase Testing in Carbapenem-Resistant Pseudomonas aeruginosa Using the ERACE-PA Global Surveillance Program
21. Transmission dynamics of ESBL-producing Escherichia coli clones in rehabilitation wards at a tertiary care centre
22. Interventional strategies and current clinical experience with carbapenemase-producing Gram-negative bacteria
23. Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe
24. Broadening the infection prevention and control network globally; 2017 Geneva IPC-think tank (part 3)
25. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
26. High rates of intestinal colonisation with fluoroquinolone-resistant ESBL-harbouring Enterobacteriaceae in hospitalised patients with antibiotic-associated diarrhoea
27. Laboratory evaluation of different agar media for isolation of carbapenem-resistant Acinetobacter spp.
28. Elevated MICs of Susceptible Antipseudomonal Cephalosporins in Non-Carbapenemase-Producing, Carbapenem-Resistant Pseudomonas aeruginosa: Implications for Dose Optimization
29. Intercontinental spread from Israel to Colombia of a KPC-3-producing Klebsiella pneumoniae strain
30. Ceftobiprole medocaril is an effective treatment against methicillin-resistant Staphylococcus aureus (MRSA) mediastinitis in a rat model
31. Phylogenetic lineages, clones and β-lactamases in an international collection of Klebsiella oxytoca isolates non-susceptible to expanded-spectrum cephalosporins
32. Case–control study to identify factors associated with mortality among patients with methicillin-resistant Staphylococcus aureus bacteraemia
33. Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control
34. Colistin resistance development following colistin-meropenem combination therapy versus colistin monotherapy in patients with infections caused by carbapenem-resistant organisms
35. Survey of metallo-β-lactamase-producing Enterobacteriaceae colonizing patients in European ICUs and rehabilitation units, 2008–11
36. MLST reveals potentially high-risk international clones of Enterobacter cloacae
37. Elevated MICs of susceptible antipseudomonal cephalosporins in non-carbapenemase-producing, carbapenem-resistant pseudomonas aeruginosa: Implications for dose optimization
38. Excluded versus included patients in a randomized controlled trial of infections caused by carbapenem-resistant Gram-negative bacteria: relevance to external validity
39. The ERACE‑PA Global Surveillance Program: Ceftolozane/tazobactam and Ceftazidime/avibactam in vitro Activity against a Global Collection of Carbapenem‑resistant Pseudomonas aeruginosa
40. Systematic review of antibiotic consumption in acute care hospitals
41. The emergence and dissemination of CTX-M-producing Escherichia coli sequence type 131 causing community-onset bacteremia in Israel
42. Culture-based detection of methicillin-resistant Staphylococcus aureus by a network of European laboratories: an external quality assessment study
43. Laboratory evaluation of the ESwab transport system for the recovery of carbapenem-resistant Acinetobacter baumannii
44. Antimicrobial susceptibility of intra-abdominal Gram-negative bacilli from Europe: SMART Europe 2008
45. Strategies for managing today's infections
46. Technology for the prevention of antimicrobial resistance and healthcare-associated infections; 2017 Geneva IPC-Think Tank (Part 2)
47. SCCmec and spa types of methicillin-resistant Staphylococcus aureus strains in Israel. Detection of SCCmec type V
48. Spread of KPC-producing carbapenem-resistant Enterobacteriaceae: the importance of super-spreaders and rectal KPC concentration
49. Impact of multi-drug-resistant Acinetobacter baumannii on clinical outcomes
50. Extended-spectrum β-lactamase-producing Shigella strains in Israel, 2000–2004
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.